StockData
Faeth Therapeutics, Inc. logo

Faeth Therapeutics, Inc. (FTH) stock

FTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$10.03−0.62 (-5.82%)

Close on Nov 13, 2026Market cap $259.18MP/E –Yield –

Faeth Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Faeth Therapeutics's market cap was $344.87M on Nov 11, 2026, against $10.62M a year earlier. Over the last 5 years it ranged from $7.60M to $846.55M, with a median of $28.33M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$344.87M+2462.6%
2025Dec 31, 2025$13.46M+9.2%
2024Dec 31, 2024$12.33M-28.7%
2023Dec 29, 2023$17.30M-62.2%
2022Dec 30, 2022$45.77M-74.2%
2021Dec 31, 2021$177.41M–

More Faeth Therapeutics figures

See a number that looks wrong?